C84.40
Peripheral T-cell lymphoma, not elsewhere classified, unspecified site
Clinical Classification Guidelines
Medical Intelligence & Overview
Peripheral T-cell lymphoma (PTCL) is a type of non-Hodgkin lymphoma, a cancer that begins in the lymphatic system. Specifically, PTCL originates from T-cells, a category of immune cells that play a key role in protecting the body from infections. When labeled as 'not elsewhere classified' and 'unspecified site,' it indicates that the exact location of the cancer within the body's tissues is unclear or cannot be precisely determined. This condition can affect various parts of the body and may present differently depending on its progression.
Causes & Symptoms
Clinical Causes: Genetic mutations within T-cells, leading to abnormal growth Exposure to certain chemicals or pesticides Infections with specific viruses, such as Epstein-Barr virus (EBV) Immune system deficiencies or suppression History of other lymphatic or immune-related diseases
Key Symptoms: Swollen or painless lymph nodes, especially in the neck, armpits, or groin Unexplained weight loss Fever that persists over time Night sweats and chills Persistent fatigue or weakness Difficulty breathing or chest pain if the lymph nodes in the chest are affected Itchiness and skin rashes in some cases Abdominal discomfort or swelling if the abdomen is involved
Diagnostic & Treatment
Diagnosis Path: Physical examination focusing on swollen lymph nodes and other symptoms Imaging tests like CT scans, PET scans, or MRI to identify affected areas Lymph node biopsies for microscopic examination of tissue samples Blood tests to assess overall health and detect abnormal cells or markers Bone marrow biopsies if the disease is suspected to involve the bone marrow Additional tests may be performed to rule out other conditions and determine the extent of the disease
Treatment Protocols: Chemotherapy, often using combination drug regimens to target cancer cells Radiation therapy to eliminate localized tumor areas Targeted therapy involving drugs that attack specific molecules involved in cancer growth Stem cell or bone marrow transplants in advanced cases Clinical trials that provide access to experimental treatments Supportive care to manage symptoms and improve quality of life
Clinical Advice & FAQs
Billing Guidance
Is C84.40 a billable ICD-10 code?
Yes, C84.40 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C84.40?
Clinical documentation must specify the nature of Peripheral T-cell lymphoma, not elsewhere classified, unspecified site and any associated comorbidities for accurate reporting.
Cite this Clinical Reference